Keyphrases
Israel
100%
COVID-19
87%
Influenza
39%
Influenza Virus
38%
Influenza-like Illness
30%
Virus
29%
Vaccination
26%
BNT162b2 Vaccine
24%
COVID-19 Pandemic
22%
Neutralizing Antibodies
20%
Immunogenicity
20%
Respiratory Syncytial Virus
19%
Influenza Season
18%
Quantitative PCR
18%
Immune Response
18%
Respiratory Viruses
17%
Omicron Variant
17%
NKp46
17%
SARS-CoV-2 Variants
16%
BNT162b2
15%
Viral
15%
Hospitalized Patients
14%
Adenovirus
14%
Vaccine Effectiveness
14%
Human Metapneumovirus (hMPV)
14%
Influenza B
14%
A(H1N1)pdm09
13%
Heart Transplant Recipients
13%
Neutralization Activity
13%
Healthcare Workers
12%
Influenza Vaccine
12%
World Health Organization
11%
H3N2
11%
Variants of Concern
11%
Humoral Response
11%
Natural Killer Cells
11%
Clinical Samples
11%
Influenza Vaccination
11%
Third Dose
10%
Influenza A
10%
Winter Season
10%
European Regions
10%
Neuraminidase
10%
Influenza A(H3N2)
9%
H3N2 Virus
9%
Hemagglutinin
9%
Breakthrough Infection
9%
BA.5
9%
COVID-19 Vaccine
9%
BA.1
9%
Immunology and Microbiology
Influenza
86%
Severe Acute Respiratory Syndrome Coronavirus 2
74%
COVID-19
50%
Virus
43%
Neutralization
33%
Omicron Coronavirus Variant
32%
Influenza A Virus (H1N1)
32%
Influenza Virus
26%
Immune Response
20%
Influenza Vaccine
20%
Neutralizing Antibody
19%
Respiratory Virus
18%
Spike
17%
Influenza A Virus (H3N2)
17%
Human Respiratory Syncytial Virus
17%
Natural Killer Cell
16%
Immunogenicity
16%
Wild Type
16%
Viral Disease
13%
Titer
12%
Humoral Immunity
12%
Adenoviridae
12%
Antibody Titer
11%
Breakthrough Infection
10%
Lineages
10%
Influenzavirus A
9%
Hemagglutinin
9%
Antibody Response
9%
Human Metapneumovirus
9%
Real-Time Polymerase Chain Reaction
8%
Dynamics
8%
Infectious Agent
8%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
Inflammatory Arthritis
7%
Coronavirinae
7%
Cladistics
7%
interferon
6%
Receptor Binding
6%
Psoriatic Arthritis
5%
Respiratory Syncytial Virus Infection
5%
Influenza B Virus
5%
Coinfection
5%
Monoclonal Antibody
5%
Adoptive Immunity
5%
Natural Cytotoxicity Triggering Receptor 1
5%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
48%
COVID-19
34%
Infection
31%
Virus
20%
Influenza Vaccine
15%
Influenza A Virus (H1N1)
13%
Influenza A Virus (H3N2)
12%
Diseases
11%
Adenoviridae
10%
Influenza Vaccination
10%
Influenza A (H3N2)
8%
Coronavirinae
8%
Influenza Virus
7%
Health Care
7%
Neutralization
7%
Influenza B
7%
Public Health
6%
Virus Infection
6%
Humoral Immunity
6%
Respiratory Tract Infection
6%
Human Metapneumovirus
6%
Rheumatoid Arthritis
6%
Inflammatory Arthritis
6%
Sentinel Surveillance
5%
Surveillance System
5%
Primary Health Care
5%
Real-Time Polymerase Chain Reaction
5%
Human Respiratory Syncytial Virus
5%
Flu Like Syndrome
5%
Immune Response
5%